Lupin’s Clinical group, located in Blue Bell, Pennsylvania, is comprised of Global Clinical Development and Clinical Operations professionals. The Clinical Operations group is a centralized function, working across different therapeutic areas. On the Clinical Development side, the group is responsible for Inhalation, Complex Injectables, and Specialty. The team oversees clinical development interactions with global regulatory authorities, protocol development, clinical trial planning, study conduct, patient safety, and data quality, while fostering good communication between study sites and sponsors. Our experience, support systems and infrastructure enable us to provide the highest level of program management and clinical development expertise.